🔎 Trials Near Me

Home › Glioblastoma › NCT07664579

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

RecruitingObservational studyHealthy volunteers welcome

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Have received a diagnosis of a primary brain tumor (glioblastoma), or other cancers (breast, lung, etc.)
* Are new patients to City of Hope (COH) (all sites) or receive at least some of their care at City of Hope- Duarte Campus (care is defined as: procedures, consults, laboratories, imaging, surgery, and/or treatment)
* The patient is in a committed relationship/partnership with a partner and the partner is available and willing to participate
* Are English or Spanish speaking
* ≥ 18 years of age
* Have access to a smartphone, computer/laptop or internet connection to complete all study procedures

Exclusion Criteria:

* Significant cognitive impairment
* Inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis)
* Visual, hearing, voice, or motor impairment that prevents completion of study procedures as evidenced by clinical judgment
* Committed partners will be excluded from the study if they:

  * Refuse to complete informed consent
  * Have cognitive impairment
  * Have severe mental illness that would prevent informed consent and completion of study activities as evidenced by clinical judgment

About the study

This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the participants with cancer.

What is being tested

Sponsor: City of Hope Medical Center · Participants: 160 · Started: Jul 5, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT07664579

Locations in the U.S.

CaliforniaCity of Hope Medical Center, Duarte

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.